Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000166023 | SCV000216782 | uncertain significance | Hereditary cancer-predisposing syndrome | 2014-10-02 | criteria provided, single submitter | clinical testing | The c.906G>A (p.L302L) alteration is located in exon 5 (coding exon 5) of the MSH2 gene. This alteration consists of a G to A substitution at nucleotide position 906. This nucleotide substitution does not change the amino acid at codon 302. However, this change occurs in the last nucleotide of Exon 5 (c.793_942) which makes it likely to have some effect on normal mRNA splicing. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |